Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05129072 · ClinicalTrials.gov registry record · NA
Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT05129072 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 75 participants.
The verdict
NCT05129072, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
This objective of this clinical study aims to confirm whether multiple kalifilcon A daily disposable toric contact lenses are providing the intended level of spherical aberration correction when worn.
Interventions
- DEVICE kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-08-25 |
| Est. Completion | 2021-09-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05129072
The ClinicalTrials.gov registry entry for NCT05129072 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D is the first listed.
NCT05129072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05129072 about?
NCT05129072 is a clinical study titled "Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses". This objective of this clinical study aims to confirm whether multiple kalifilcon A daily disposable toric contact lenses are providing the intended level of spherical aberration correction when worn.
What is the current status of trial NCT05129072?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2021-08-25. Estimated completion is 2021-09-24.
What interventions are being tested in trial NCT05129072?
The interventions under investigation include: kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D (DEVICE).
Who is sponsoring clinical trial NCT05129072?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.